Alphabet Inc.
An institutional investment manager in Mountain View, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 7, 2026. SEC CIK 1652044.
- Reported value$99.08bn
- Positions28
Holdings: 28 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 29 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$bn | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Space Exploration Techn CorpSPCX | CLASS A COM STK | 84615Q103 | 94.2 | 95.0% | 551,189,500 | New+551,189,500 | |
| Planet Labs PBCPL | COM CL A | 72703X106 | 1.2 | 1.2% | 35,248,893 | Unchanged | |
| AST Spacemobile IncASTS | COM CL A | 00217D100 | 0.8 | 0.8% | 8,943,486 | Unchanged | |
| CME Group IncCME | COM | 12572Q105 | 0.8 | 0.8% | 3,484,020 | Unchanged | |
| ARM Holdings plcARM | SPONSORED ADS | 042068205 | 0.7 | 0.7% | 1,960,784 | Unchanged | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.6 | 0.6% | 2,946,619 | Reduced−345,906 | |
| Freshworks IncFRSH | CLASS A COM | 358054104 | 0.2 | 0.2% | 16,206,643 | Unchanged | |
| Parabilis Medicines IncPBLS | COM | 698955101 | 0.1 | 0.1% | 4,919,498 | New+4,919,498 | |
| Tempus Ai IncTEM | CL A | 88023B103 | 0.1 | <0.1% | 1,551,102 | Unchanged | |
| Gitlab IncGTLB | CLASS A COM | 37637K108 | 0.1 | <0.1% | 2,724,712 | Unchanged | |
| Uipath IncPATH | CL A | 90364P105 | 0.1 | <0.1% | 7,034,337 | Unchanged | |
| Ethos Technologies IncLIFE | CL A | 29765A101 | 0.1 | <0.1% | 3,622,604 | Reduced−147,552 | |
| Prime Medicine IncPRME | COM | 74168J101 | 0.1 | <0.1% | 16,562,498 | Unchanged | |
| Fervo Energy CoFRVO | CL A COM | 31556C106 | 0.1 | <0.1% | 1,760,732 | New+1,760,732 | |
| Paypay CorpPAYP | SPONSORED ADS | 70450C101 | 0.0 | <0.1% | 3,125,000 | Unchanged | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | <0.1% | 1,388,583 | Unchanged | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 0.0 | <0.1% | 1,410,029 | Reduced−154,144 | |
| Bridgebio Oncology TherapeutBBOT | COM NEW | 107924102 | 0.0 | <0.1% | 2,823,126 | Unchanged | |
| Oscar Health IncOSCR | CL A | 687793109 | 0.0 | <0.1% | 481,988 | Unchanged | |
| Beam Therapeutics IncBEAM | COM | 07373V105 | 0.0 | <0.1% | 321,604 | Unchanged | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 0.0 | <0.1% | 241,264 | Unchanged | |
| Sana Biotechnology IncSANA | COM | 799566104 | 0.0 | <0.1% | 2,812,500 | Unchanged | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 0.0 | <0.1% | 372,474 | Reduced−311,801 | |
| Lyell Immunopharma IncLYEL | COM NEW | 55083R203 | 0.0 | <0.1% | 293,256 | Unchanged | |
| Figma IncFIG | CLASS A COM STK | 316841105 | 0.0 | <0.1% | 215,582 | Unchanged | |
| Spero Therapeutics IncSPRO | COM | 84833T103 | 0.0 | <0.1% | 889,979 | Unchanged | |
| Hyperfine IncHYPR | COM CL A | 44916K106 | 0.0 | <0.1% | 898,720 | Unchanged | |
| Autolus Therapeutics plcAUTL | SPON ADS | 05280R100 | 0.0 | <0.1% | 698,262 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics IncTNYA | COM | 87990A106 | 0.0 | 0.0% | 0 | Sold out−915,705 |
Source: SEC EDGAR, Form 13F-HR, accession 0001652044-26-000073 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.